insights_auto
Why is ARWR down 2.88%?
Dive Deeperchevron_right
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$60.94
arrow_downward
-2.88%(-1.81) 1D
Oct 12, 2:25:45 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$62.49
High
$62.50
Low
$60.52
Mkt. cap
8.61B
Avg. vol.
2.14M
Volume
412.60K
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$62.49
High
$62.50
Low
$60.52
Mkt. cap
8.61B
Avg. vol.
2.14M
Volume
412.60K
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Simply Wall Street
·
11 hours ago
Arrowhead Pharmaceuticals (ARWR) Climbed Today, What Is Behind The Move?
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com